PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3) expression is increased in cancer and it acts as an allosteric activator of the glycolytic enzyme phosphofructokinase 1 (PFK1), stimulating glycolysis (52). Here, PFKM is linked to cancer.